RYZTOMEV

Serial Number 99170020
601

Registration Progress

Application Filed
May 5, 2025
Under Examination
Approved for Publication
Published for Opposition
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: RYZTOMEV
Previous Owner: Pfizer Inc.
Classes: 005

Trademark Image

RYZTOMEV

Basic Information

Serial Number
99170020
Filing Date
May 5, 2025
Abandonment Date
August 20, 2025
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
601
Status Date
Aug 21, 2025
Classes
005

Rights Holder

Pfizer Inc.

03
Address
66 Hudson Boulevard East
New York, NY 10001-2192

Ownership History

Pfizer Inc.

Original Applicant
03
New York, NY

Legal Representation

Attorney
Tiffany Trunko

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

10 events
Date Code Type Description Documents
Aug 21, 2025 MAB1 E ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT Loading...
Aug 21, 2025 ABN1 O ABANDONMENT - EXPRESS MAILED Loading...
Aug 20, 2025 EXAR I TEAS EXPRESS ABANDONMENT RECEIVED Loading...
Aug 1, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Aug 1, 2025 GNRT F NON-FINAL ACTION E-MAILED Loading...
Aug 1, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jul 30, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
May 5, 2025 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
May 5, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 5, 2025 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use.

Classification

International Classes
005